{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T05:37:02Z","timestamp":1775453822025,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,5]]},"DOI":"10.7759\/cureus.106488","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T04:20:42Z","timestamp":1775449242000},"source":"Crossref","is-referenced-by-count":0,"title":["Drug Utilization and Safety Profile of Intravenous Iron Isomaltoside 1000 in Cancer Patients With Iron Deficiency Anemia: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Kartik Kumar","family":"Anil Kumar Purohit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitesh Kumar","family":"Dilip Kumar Halvawala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000083128","article-title":"Cancer-related anemia: pathogenesis, prevalence and treatment","volume":"68","author":"Birgeg\u00e5rd G","year":"2005","unstructured":"Birgeg\u00e5rd G, Aapro MS, Bokemeyer C, et al.. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology. 2005, 68:3-11. 10.1159\/000083128","journal-title":"Oncology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.26502\/JCSCT.5079241","article-title":"Anemia correction: small step towards survival in cancer patients","volume":"8","author":"Parikh P","year":"2024","unstructured":"Parikh P, Gaikwad A. Anemia correction: small step towards survival in cancer patients. J Cancer Sci Clin Ther. 2024, 8:203-7. 10.26502\/JCSCT.5079241","journal-title":"J Cancer Sci Clin Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104788","article-title":"Anaemia in cancer patients: advances and challenges in the era of precision oncology","volume":"213","author":"Miglietta F","year":"2025","unstructured":"Miglietta F, Pirozzi M, Bottosso M, Pisani C, Franco P, Guarneri V, Gennari A. Anaemia in cancer patients: advances and challenges in the era of precision oncology. Crit Rev Oncol Hematol. 2025, 213:10.1016\/j.critrevonc.2025.104788","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163817","article-title":"Iron deficiency anemia coexists with cancer related anemia and adversely impacts quality of life","volume":"11","author":"Kanuri G","year":"2016","unstructured":"Kanuri G, Sawhney R, Varghese J, Britto M, Shet A. Iron deficiency anemia coexists with cancer related anemia and adversely impacts quality of life. PLoS One. 2016, 11:10.1371\/journal.pone.0163817","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1771445","article-title":"Practical clinical consensus guidelines for the management of cancer associated anemia in low- and middle-income countries","volume":"12","author":"Parikh PM","year":"2023","unstructured":"Parikh PM, Aggarwal S, Biswas G, et al.. Practical clinical consensus guidelines for the management of cancer associated anemia in low- and middle-income countries. South Asian J Cancer. 2023, 12:93-9. 10.1055\/s-0043-1771445","journal-title":"South Asian J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2217\/fon.11.24","article-title":"Management of anemia in cancer patients","volume":"7","author":"Calabrich A","year":"2011","unstructured":"Calabrich A, Katz A. Management of anemia in cancer patients. Future Oncol. 2011, 7:507-17. 10.2217\/fon.11.24","journal-title":"Future Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx758","article-title":"Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines","volume":"29","author":"Aapro M","year":"2018","unstructured":"Aapro M, Beguin Y, Bokemeyer C, et al.. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018, 29:96-110. 10.1093\/annonc\/mdx758","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004017","article-title":"How I treat cancer-associated anemia","volume":"136","author":"Gilreath JA","year":"2020","unstructured":"Gilreath JA, Rodgers GM. How I treat cancer-associated anemia. Blood. 2020, 136:801-13. 10.1182\/blood.2019004017","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1988.28588337325.x","article-title":"Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients","volume":"28","author":"Escolar G","year":"1988","unstructured":"Escolar G, Garrido M, Mazzara R, Castillo R, Ordinas A. Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. Transfusion. 1988, 28:406-11. 10.1046\/j.1537-2995.1988.28588337325.x","journal-title":"Transfusion"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv293","article-title":"A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia","volume":"31","author":"Kalra PA","year":"2016","unstructured":"Kalra PA, Bhandari S, Saxena S, et al.. A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia. Nephrol Dial Transplant. 2016, 31:646-55. 10.1093\/ndt\/gfv293","journal-title":"Nephrol Dial Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02180-2","article-title":"NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease","volume":"21","author":"Kalra PA","year":"2020","unstructured":"Kalra PA, Bhandari S, Spyridon M, et al.. NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease. BMC Nephrol. 2020, 21:539. 10.1186\/s12882-020-02180-2","journal-title":"BMC Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2019.1575202","article-title":"A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment","volume":"12","author":"Pollock RF","year":"2019","unstructured":"Pollock RF, Muduma G. A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment. Expert Rev Hematol. 2019, 12:129-36. 10.1080\/17474086.2019.1575202","journal-title":"Expert Rev Hematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijogr.2022.105","article-title":"To observe the rise in haemoglobin concentration levels by parenteral iron infusion of iron isomaltoside 1000 (Fur-IV) in gynaecological patients suffering from iron deficiency anaemia","volume":"9","author":"Pandya MR","year":"2022","unstructured":"Pandya MR, Patel KK. To observe the rise in haemoglobin concentration levels by parenteral iron infusion of iron isomaltoside 1000 (Fur-IV) in gynaecological patients suffering from iron deficiency anaemia. Indian J Obstet Gynecol Res. 2022, 9:553-7. 10.18231\/j.ijogr.2022.105","journal-title":"Indian J Obstet Gynecol Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20251433","article-title":"Drug utilization study and safety profile of iron isomaltoside 1000 in treatment of iron deficiency anemia in cancer patients: a retrospective study","volume":"13","author":"Paul D","year":"2025","unstructured":"Paul D, Mahajan M, Bharat S, Tripathi R. Drug utilization study and safety profile of iron isomaltoside 1000 in treatment of iron deficiency anemia in cancer patients: a retrospective study. Int J Res Med Sci. 2025, 13:2409-13. 10.18203\/2320-6012.ijrms20251433","journal-title":"Int J Res Med Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/473502-drug-utilization-and-safety-profile-of-intravenous-iron-isomaltoside-1000-in-cancer-patients-with-iron-deficiency-anemia-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T04:20:42Z","timestamp":1775449242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/473502-drug-utilization-and-safety-profile-of-intravenous-iron-isomaltoside-1000-in-cancer-patients-with-iron-deficiency-anemia-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,5]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.106488","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,5]]}}}